Human immunodeficiency virus 1 tat peptide (49-57)

a transfection enhancer

Also Known As:

tat peptide (49-57), Human immunodeficiency virus 1; Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg; HIV-1 tat protein (49-57); RKKRRQRRR; arginyl-lysyl-lysyl-arginyl-arginyl-glutaminyl-arginyl-arginyl-arginine

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
- Peptides: 82426
  - Peptide Fragments: 373
    - Human immunodeficiency virus 1 tat peptide (49-57): 3

Experts

1.	Feng, Qiqi: 1 article (01/2020)
2.	Gui, Lin: 1 article (01/2020)
3.	Li, Yuanming: 1 article (01/2020)
4.	Song, Songlin: 1 article (01/2020)
5.	Taledaohan, Ayijiang: 1 article (01/2020)
6.	Wang, Wei: 1 article (01/2020)
7.	Wang, Yanming: 1 article (01/2020)
8.	Wang, Yuji: 1 article (01/2020)
9.	Chen, Xiaolong: 1 article (01/2018)
10.	Chen, Yuxin: 1 article (01/2018)

Related Diseases

1.	Neoplasms (Cancer) 12/01/2016 - "RKKRRQRRR peptide (TAT) modified, DTX and pDNA loaded LPNs (TAT-DTX/pDNA LPNs) were prepared and evaluated in PC3 cancer cells (in vitro) and in a murine prostate cancer model (in vivo). " 01/01/2020 - "To enhance the antitumor activity, the PAD4 inhibitor 356 was modified by the well-established cationic penetrating peptide RKKRRQRRR (peptide TAT) and gold nanoparticles to obtain 356-TAT-AuNPs which could enhance the permeability of chemical drug in solid tumor. " 01/01/2018 - "To enhance the anticancer activity, tumor penetration ability of the hybrid anticancer peptide, in this study, a TAT (RKKRRQRRR) peptide modified kla peptide (KLAKLAKKLAKLAK, with all D-amino acids), named kla-TAT, was co-administrated with the homing/penetrating peptide iRGD which could enhance the permeability of chemical drug in solid tumor and tumor vessel by co-administration. "
2.	Prostatic Neoplasms (Prostate Cancer) 12/01/2016 - "RKKRRQRRR peptide (TAT) modified, DTX and pDNA loaded LPNs (TAT-DTX/pDNA LPNs) were prepared and evaluated in PC3 cancer cells (in vitro) and in a murine prostate cancer model (in vivo). "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Amino Acids
3.	KLA peptide
4.	Gold